Clinical Chemistry, Malmö
1 – 10 of 1328
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
(
- Contribution to journal › Article
-
Mark
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes
(
- Contribution to journal › Scientific review
-
Mark
Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer
2025) In Journal of the National Cancer Institute(
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
2025) In JAMA Oncology(
- Contribution to journal › Article
-
Mark
Cold activation in PT-INR samples–Myth or reality in the modern laboratory?
(
- Contribution to journal › Article
-
Mark
Practical handling of hemolytic, icteric and lipemic samples for coagulation testing in European laboratories. A collaborative survey from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
(
- Contribution to journal › Article
-
Mark
Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
(
- Contribution to journal › Article
-
Mark
Short-term effects of follicle-stimulating hormone on immune function, lipid, and vitamin metabolism in transiently castrated men
(
- Contribution to journal › Article
-
Mark
Toward Improved Prostate Cancer Screening : Insights from the Göteborg-2 Trial
(
- Contribution to journal › Letter